Correlation of Treatment Time and Ultrafiltration Rate with Serum Albumin and C-Reactive Protein Levels in Patients with End-Stage Kidney Disease Receiving Chronic Maintenance Hemodialysis: A Cross-Sectional Study
Lajos Zsom(Egis Pharmaceuticals (Hungary)), Giovanni FM Strippoli(The University of Sydney), Jörgen Hegbrant(Lund University), Tibor Fülöp(Medical University of South Carolina), Michael F. Flessner, Catherine Wells(National Cancer Institute), Charlotta Wollheim, József Eller(University of Szeged), Marianna Zsom
Cited by 12
Related Papers
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2014|524
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
|The Lancet|2015|394
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis
|Canadian Medical Association Journal|2013|307
Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2014|290
Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure
|New England Journal of Medicine|2023|287